GlassScriptPhysician profile
Mauricio Davalos
NPI 1114179678
$8,522.29
in general payments reported to CMS, 2019-2025
38 companies · $1,466 in 2025
The $1,466 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $737 · 2020: $212 · 2021: $795 · 2022: $1,940 · 2023: $1,868 · 2024: $1,504 · 2025: $1,466.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,839.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,838.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $1,628.20 | 2021-2024 | Axonics, Bulkamid |
| Procept Biorobotics Corporation | $1,152.16 | 2021-2025 | Aquabeam Robotic System, Aquabeam System |
| Sumitomo Pharma America, INC. | $884.53 | 2023-2025 | Gemtesa |
| Astellas Pharma US INC | $635.95 | 2019-2023 | Myrbetriq |
| Abbvie INC. | $619.23 | 2019-2025 | Botox |
| Boston Scientific Corporation | $427.06 | 2019-2025 | Axonics |
| Calyxo, INC. | $414.41 | 2023-2025 | Cvac Aspiration System |
| Merck Sharp & Dohme LLC | $233.59 | 2019-2024 | Keytruda, Lynparza |
| Amgen INC. | $204.73 | 2019-2022 | |
| Laborie Medical Technologies Corp. | $192.84 | 2022-2023 | |
| Ge Healthcare | $186.04 | 2024 | |
| Ferring Pharmaceuticals INC. | $182.44 | 2019-2025 | Adstiladrin |
| Progenics Pharmaceuticals, INC. | $176.89 | 2022-2023 | Pylarify |
| Valencia Technologies Corporation | $153.69 | 2024 | Ecoin Device Kit |
| Teleflex LLC | $129.87 | 2021 |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| 180 Medical, INC. | $123.95 | 2020-2023 | Cure Catheter |
| Urovant Sciences INC | $120.47 | 2021-2022 | |
| Urogen Pharma, INC. | $113.96 | 2023-2025 | Jelmyto |
| Visionrt, INC. | $113.26 | 2025 | |
| Allergan, INC. | $107.08 | 2020-2021 | |
| Myriad Genetic Laboratories, INC. | $87.97 | 2021-2023 | Bracanalysis Cdx |
| Bayer Healthcare Pharmaceuticals INC. | $87.05 | 2021-2023 | |
| Antares Pharma, INC. | $79.13 | 2021-2023 | Xyosted, Tlando, Nocdurna |
| Medtronic, INC. | $68.90 | 2024-2025 | Interstim, Altaviva |
| Caldera Medical, INC | $50.71 | 2023 | Desara |
| Coloplast Corp | $45.39 | 2019-2024 | |
| Agiliti Surgical, INC. | $40.55 | 2019-2020 | |
| Ethicon US, LLC | $36.90 | 2021 | |
| Ambu INC. | $34.21 | 2024 | |
| Tolmar Pharmaceuticals, INC. | $30.08 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $28.51 | 2024 | |
| Cycle Pharmaceuticals INC | $24.39 | 2025 | Venxxiva |
| Dendreon Pharmaceuticals LLC | $20.80 | 2019 | |
| Tolmar, INC. | $20.02 | 2023 | |
| Pfizer INC. | $19.69 | 2025 | |
| Janssen Biotech, INC. | $19.35 | 2020 | |
| Endo USA, INC. | $15.53 | 2025 | Xiaflex, Aveed |
| Richard Wolf Medical Instruments Corp. | $12.76 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mauricio Davalos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.